EDMONTON, Jan. 26 /PRNewswire-FirstCall/ - Biomira Inc. announced its Web cast vendor, Verizon/MCI, has finally resolved several technical issues. A replay of today’s conference call to discuss amendments to its licensing agreement with Merck KGaA of Darmstadt, Germany for BLP25 Liposome Vaccine (L-BLP25) is now available on the web.
To access the call, please click on to the following link:
https://e-meetings.mci.com/emeet/awe/index.jsp?customerHeader(equal
sign)emeetings&CONFERENCE_ID(equal sign)1540590&PASSWORD(equal sign)BIOMIRA. When you proceed to the web cast page you must then fill in personal information, click on “Proceed”. On the next page click on “Join” underneath the audio player logos to access the replay. The archive of the analyst conference call will be available for approximately 30 days.
About Biomira Inc.
Biomira is a biotechnology company specializing in the development of innovative therapeutic approaches to cancer management. Biomira’s commitment to the treatment of cancer currently focuses on the development of synthetic vaccines and novel strategies for cancer immunotherapy.
Biomira Inc.
CONTACT: Biomira Company Contacts: Media Relations, Bill Wickson, Manager,Public Relations, (780) 490-2818; Investor Relations, Jane Tulloch,Director, Investor Relations, (780) 490-2812; U.S. Media Contact: JonathanBirt, Financial Dynamics, (212) 850-5634, jbirt@fd-us.com; U.S. InvestorContact: John Capodanno, Financial Dynamics, (212) 850-5705,jcapodanno@fd-us.com; To request a free copy of this organization’s annualreport, please go to http://www.newswire.ca and click on Tools forInvestors.